Comparison of ranitidine, domperidone maleate and ranitidine + domperidone maleate in the short-term treatment of reflux oesophagitis

E. Masci, P. A. Testoni, S. Passaretti, M. Guslandi, A. Tittobello

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

In the treatment of reflux oesophagitis, either drugs preventing regurgitation of gastric juice in the lower oesophagus or pharmacological agents increasing the pH of the refluxing material are employed. In the present study 45 outpatients with reflux oesophagitis were randomly treated with either ranitidine (150 mg b.i.d.) or domperidone maleate (20 mg t.i.d.) or both drugs for six weeks. Before and after treatment the severity of dyspeptic symptoms and the grade of endoscopic and histological changes were assessed. The three therapeutic regimens were significantly and equally effective in inducing symptomatic relief and promoting endoscopic and histological disappearance or improvement of oesophagitis. The combined use of ranitidine and domperidone maleate failed to show any additional benefit compared with treatment with either drug alone.

Original languageEnglish
Pages (from-to)687-692
Number of pages6
JournalDrugs under Experimental and Clinical Research
Volume11
Issue number10
Publication statusPublished - 1985

Fingerprint

Domperidone
Peptic Esophagitis
Ranitidine
Pharmaceutical Preparations
Gastric Juice
Esophagitis
Therapeutics
Esophagus
Outpatients
Pharmacology

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology (medical)
  • Pharmacology
  • Drug Discovery

Cite this

Comparison of ranitidine, domperidone maleate and ranitidine + domperidone maleate in the short-term treatment of reflux oesophagitis. / Masci, E.; Testoni, P. A.; Passaretti, S.; Guslandi, M.; Tittobello, A.

In: Drugs under Experimental and Clinical Research, Vol. 11, No. 10, 1985, p. 687-692.

Research output: Contribution to journalArticle

@article{18742cdc970c499cbef8c011e1602b9c,
title = "Comparison of ranitidine, domperidone maleate and ranitidine + domperidone maleate in the short-term treatment of reflux oesophagitis",
abstract = "In the treatment of reflux oesophagitis, either drugs preventing regurgitation of gastric juice in the lower oesophagus or pharmacological agents increasing the pH of the refluxing material are employed. In the present study 45 outpatients with reflux oesophagitis were randomly treated with either ranitidine (150 mg b.i.d.) or domperidone maleate (20 mg t.i.d.) or both drugs for six weeks. Before and after treatment the severity of dyspeptic symptoms and the grade of endoscopic and histological changes were assessed. The three therapeutic regimens were significantly and equally effective in inducing symptomatic relief and promoting endoscopic and histological disappearance or improvement of oesophagitis. The combined use of ranitidine and domperidone maleate failed to show any additional benefit compared with treatment with either drug alone.",
author = "E. Masci and Testoni, {P. A.} and S. Passaretti and M. Guslandi and A. Tittobello",
year = "1985",
language = "English",
volume = "11",
pages = "687--692",
journal = "Drugs under Experimental and Clinical Research",
issn = "0378-6501",
publisher = "Bioscience Ediprint Inc.",
number = "10",

}

TY - JOUR

T1 - Comparison of ranitidine, domperidone maleate and ranitidine + domperidone maleate in the short-term treatment of reflux oesophagitis

AU - Masci, E.

AU - Testoni, P. A.

AU - Passaretti, S.

AU - Guslandi, M.

AU - Tittobello, A.

PY - 1985

Y1 - 1985

N2 - In the treatment of reflux oesophagitis, either drugs preventing regurgitation of gastric juice in the lower oesophagus or pharmacological agents increasing the pH of the refluxing material are employed. In the present study 45 outpatients with reflux oesophagitis were randomly treated with either ranitidine (150 mg b.i.d.) or domperidone maleate (20 mg t.i.d.) or both drugs for six weeks. Before and after treatment the severity of dyspeptic symptoms and the grade of endoscopic and histological changes were assessed. The three therapeutic regimens were significantly and equally effective in inducing symptomatic relief and promoting endoscopic and histological disappearance or improvement of oesophagitis. The combined use of ranitidine and domperidone maleate failed to show any additional benefit compared with treatment with either drug alone.

AB - In the treatment of reflux oesophagitis, either drugs preventing regurgitation of gastric juice in the lower oesophagus or pharmacological agents increasing the pH of the refluxing material are employed. In the present study 45 outpatients with reflux oesophagitis were randomly treated with either ranitidine (150 mg b.i.d.) or domperidone maleate (20 mg t.i.d.) or both drugs for six weeks. Before and after treatment the severity of dyspeptic symptoms and the grade of endoscopic and histological changes were assessed. The three therapeutic regimens were significantly and equally effective in inducing symptomatic relief and promoting endoscopic and histological disappearance or improvement of oesophagitis. The combined use of ranitidine and domperidone maleate failed to show any additional benefit compared with treatment with either drug alone.

UR - http://www.scopus.com/inward/record.url?scp=0022350003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022350003&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 687

EP - 692

JO - Drugs under Experimental and Clinical Research

JF - Drugs under Experimental and Clinical Research

SN - 0378-6501

IS - 10

ER -